The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis - Poll - MDSpire

The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis

  • By

  • Jiang Yu

  • Yong Peng

  • May 20, 2026

  • 0 min

Share

Original Source(s)

The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis

  • by Jiang Yu, Yong Peng

  • May 20, 2026

Related Content

Editorial: Cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies

Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking

  • May 1, 2026

Editorial: Metabolic and biomechanical factors in bone fragility: new frontiers in understanding and managing osteoporosis